1.Toxifolin inhibits malignant biological behaviors of bladder cancer T24 cells via Rac1/NF-κB/AKT signaling pathway
Tong LU ; Xiaoke YUAN ; Tianying FU ; Yonggang SHAO ; Yingwen LU
Chinese Journal of Cancer Biotherapy 2025;32(6):604-610
Objective:To investigate the effect of toxifolin(TAX)on the malignant biological behaviors of human bladder cancer T24 cells through the Rac1/NF-κB/AKT signaling pathway.Methods:Bladder cancer T24 cells were routinely cultured and divided into:Ctrl group(untreated),TAX-L group(5 μmol/L TAX),TAX-M group(10 μmol/L TAX),TAX-H group(20 μmol/L TAX),and TAX-H+Rac1 activator group(20 μmol/L TAX+50 nmol/L ML-097).CCK-8 method,clone formation assay,scratch healing assay,Transwell chamber assay,and flow cytometry were used to evaluate the effects of different concentrations of TAX on the proliferation,migration,invasion,and apoptosis of T24 cells.WB method was used to examine the expression of apoptosis-related proteins,epithelial-mesenchymal transition(EMT)-related proteins,and Rac1/NF-κB/AKT axis related proteins in T24 cells;A nude mice xenograft model was used to assess the effect of TAX on tumor growth.Results:TAX dose-dependently inhibited the proliferation,migration,and invasion of T24 cells and promoted apoptosis(all P<0.05).TAX also increased the expression of apoptosis proteins BAX and E-cadherin,while decreasing the expression of Bcl-2,N-cadherin,and Rac1/NF-κB/AKT signaling pathway-related proteins(all P<0.05).Furthermore,TAX inhibited tumor growth in the xenograft model(P<0.05).ML-097 partially reversed these effects(all P<0.05).Conclusion:TAX inhibits the malignant biological behaviors of bladder cancer T24 cells and promotes their apoptosis by inhibiting Rac1/NF-κB/AKT signaling pathway.
2.Ultrasound biomicroscopy imaging for diagnosing chestnut thorn foreign bodies in anterior segment
Lu LU ; Ying WANG ; Chi ZHANG ; Tianying FU ; Jinxi GUO ; Wei WEI ; Yingwen LU
Chinese Journal of Interventional Imaging and Therapy 2024;21(12):752-755
Objective To observe the value of ultrasonic biomicroscopy(UBM)imaging for diagnosing chestnut thorn foreign bodies in anterior segment.Methods A total of 70 patients who underwent UBM examination due to chestnut thorn injury or residue of chestnut thorn after removal and then operation were retrospectively enrolled.The distance of chestnut thorn foreign bodies from corneal limbus,and the subconjunctival depth and length of them were measured based on UBM imaging.The efficacy of UBM for diagnosing chestnut thorn foreign bodies in anterior segment was evaluated according to surgical findings,and the correlation of quantitative parameters of foreign bodies were analyzed.Results Among 70 cases of chestnut thorn foreign bodies in anterior segment,single ocular tissue(5/70,7.14%)involvement was detected in 5 cases,while multiple ocular tissues involvement(65/70,92.86%)were noticed in 65 cases according to UBM.Totally 109 foreign bodies were detected by UBM,among which 98 were consistent with surgical findings,with the diagnostic accuracy of 89.91%(98/109),while 11 foreign bodies were not found during operation,with the false positive rate of 10.09%(11/109).Meanwhile,4 foreign bodies found and removed with operation were not displayed with UBM,and the false negative rate of UBM was 3.92%(4/102).Among 98 chestnut thorn foreign bodies correctly diagnosed with UBM,10 located in stromal layer of cornea(10/98,10.20%)and 88 located in ocular wall(88/98,89.80%),including 43 subconjunctival(43/88,48.86%)and 45 sclerotic(45/88,51.14%)foreign bodies,with the median length of 0.200 mm.The distance of 88 foreign bodies in ocular wall from corneal limbus was(2.963±1.504)mm,and the subconjunctival depth was(0.785±0.388)mm.The distance of foreign bodies from corneal limbus were positively correlated with their subconjunctival depth(r,=0.361,P<0.010),while their lengths were not correlated with their distance from corneal limbus and subconjunctival depth(both P>0.05).Conclusion UBM imaging was valuable for clinical diagnosis and localization of chestnut thorn foreign bodies in anterior segment.
3.Status quo of the selection of intravenous infusion devices in hospitalized children
Qingqing ZHANG ; Ying GU ; Yingwen WANG ; Chunmei LU ; Meijing KONG
Chinese Journal of Modern Nursing 2024;30(14):1923-1927
Objective:To investigate the status quo of intravenous (IV) infusion device selection among hospitalized children and provide direction for improving practices related to the selection of infusion devices.Methods:A total of 1 306 hospitalized children undergoing IV infusion treatment in 11 clinical departments of Children's Hospital of Fudan University in June 2021 were selected by convenience sampling. A self-developed data collection form for the selection of IV infusion devices in hospitalized children and criteria for the appropriateness of IV infusion device selection were used to survey and evaluate the appropriateness of IV infusion device selection among these children.Results:IV infusion devices were found to have been appropriately selected in 1 137 of the 1 306 children, while these devices were inappropriately selected in 169 children. The inappropriate selection was primarily due to the improper choice of peripheral intravenous catheters (PIVC), with 155 cases involving the administration of non-peripheral compatible medications through PIVC. No significant statistical difference was found in the appropriateness of IV infusion device selection between the infant group and the child and adolescent group ( P>0.05). Significant differences were observed in the appropriateness of IV infusion device selection based on different physicochemical properties of medications and the duration of therapy ( P<0.01) . Conclusions:The standardization of IV infusion device selection among hospitalized children needs improvement. It is urgent to apply evidence from the Clinical Practice Evidence- Based Guidelines for Pediatric Intravenous Therapy regarding recommendations for IV infusion device selection, to initiate evidence application projects, and to standardize the selection of IV infusion devices.
4.Hepatic arterial infusion chemotherapy versus transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma:a comparative study
Luhao CHEN ; Yi YANG ; Jingwen ZHANG ; Qi LIU ; Junrong LU ; Yingwen HOU ; Yan LIU
Journal of Interventional Radiology 2024;33(5):543-548
Objective To discuss the efficacy and safety of transarterial chemoembolization(TACE)and hepatic arterial infusion chemotherapy(HAIC)combined with tyrosine kinase inhibitors(TKI)and immune checkpoint inhibitors(ICI)for advanced hepatocellular carcinoma(HCC).Methods A total of 101 patients with unresectable HCC,who were admitted to the Affiliated Cancer Hospital of Harbin Medical University of China between January 2021 and October 2022 to receive treatment,were enrolled in this study.Of the 101 patients,50 received TACE+TKI+ICI therapy(TACE+TKI+ICI group)and 51 received HAIC+TKI+ICI therapy(HAIC+TKI+ICI group).The overall survival(OS)and the progression-free survival(PFS)were compared between the two groups,and the adverse events were analyzed to assess the safety of the therapeutic scheme.Results The median PFS in the TACE+TKI+ICI group was 12.0 months,which in the HAIC+TKI+ICI group was 11.0 months(P=0.030).The median OS was not achieved in the TACE+TKI+ICI group,which in the HAIC+TKI+ICI group was 14.6 months(P=0.005).The most common adverse effects in the TACE+TKI+ICI group were the elevation of total bilirubin(46.0%)and hepatic function injury(26.0%),which in the HAIC+TKI+ICI group were the decrease of albumin level(62.7%),fatigue(39.2%),and gastrointestinal reactions(31.4%).Conclusion For the treatment of advanced HCC,the therapeutic scheme of TACE+TKI+ICI has a better long-term survival benefits and the therapeutic scheme of HAIC+TKI+ICI can better maintain the liver function reserve of the patients.Neither therapeutic scheme shows any unexpected toxicity,and both therapeutic schemes have high clinical safety.(J Intervent Radiol,2024,33:543-548)
5.Ultrasound biomicroscopy imaging for diagnosing chestnut thorn foreign bodies in anterior segment
Lu LU ; Ying WANG ; Chi ZHANG ; Tianying FU ; Jinxi GUO ; Wei WEI ; Yingwen LU
Chinese Journal of Interventional Imaging and Therapy 2024;21(12):752-755
Objective To observe the value of ultrasonic biomicroscopy(UBM)imaging for diagnosing chestnut thorn foreign bodies in anterior segment.Methods A total of 70 patients who underwent UBM examination due to chestnut thorn injury or residue of chestnut thorn after removal and then operation were retrospectively enrolled.The distance of chestnut thorn foreign bodies from corneal limbus,and the subconjunctival depth and length of them were measured based on UBM imaging.The efficacy of UBM for diagnosing chestnut thorn foreign bodies in anterior segment was evaluated according to surgical findings,and the correlation of quantitative parameters of foreign bodies were analyzed.Results Among 70 cases of chestnut thorn foreign bodies in anterior segment,single ocular tissue(5/70,7.14%)involvement was detected in 5 cases,while multiple ocular tissues involvement(65/70,92.86%)were noticed in 65 cases according to UBM.Totally 109 foreign bodies were detected by UBM,among which 98 were consistent with surgical findings,with the diagnostic accuracy of 89.91%(98/109),while 11 foreign bodies were not found during operation,with the false positive rate of 10.09%(11/109).Meanwhile,4 foreign bodies found and removed with operation were not displayed with UBM,and the false negative rate of UBM was 3.92%(4/102).Among 98 chestnut thorn foreign bodies correctly diagnosed with UBM,10 located in stromal layer of cornea(10/98,10.20%)and 88 located in ocular wall(88/98,89.80%),including 43 subconjunctival(43/88,48.86%)and 45 sclerotic(45/88,51.14%)foreign bodies,with the median length of 0.200 mm.The distance of 88 foreign bodies in ocular wall from corneal limbus was(2.963±1.504)mm,and the subconjunctival depth was(0.785±0.388)mm.The distance of foreign bodies from corneal limbus were positively correlated with their subconjunctival depth(r,=0.361,P<0.010),while their lengths were not correlated with their distance from corneal limbus and subconjunctival depth(both P>0.05).Conclusion UBM imaging was valuable for clinical diagnosis and localization of chestnut thorn foreign bodies in anterior segment.
6.Analysis of TUBB2B gene variant in a fetus with complex cortical dysplasia with other brain malformations-7.
Lulu YAN ; Zhaier LU ; Yingwen LIU ; Chunxiao HAN ; Hongjun YING ; Youwei BAO ; Jiangyang XUE ; Haibo LI
Chinese Journal of Medical Genetics 2022;39(3):301-304
OBJECTIVE:
To explore the genetic basis for a fetus with dysgenesis of corpus callosum and other brain malformations.
METHODS:
Whole exome sequencing was carried out for the fetus and its parents. Suspected pathogenic variants were verified by Sanger sequencing.
RESULTS:
A novel de novo missense variant c.758T>A (p.L253Q) of the TUBB2B gene was identified, which was unreported previously. Based on the guidelines from the American College of Medical Genetics, the c.758T>A variant was predicted to be likely pathogenic. Bioinformatics analysis predicted that the leucine at position 253 was highly conserved among various species, and the c.758T>A variant may impact the formation of hydrogen bonds between Leu253 and Asp249 and Met257 residues, which in turn may affect the combination of GTP/GDP and function of the TUBB2B protein.
CONCLUSION
The c.758T>A variant of the TUBB2B gene probably underlay the fetal malformations in this Chinese family. Above discovery has enriched the spectrum of TUBB2B gene variants and provided a basis for genetic counseling and prenatal diagnosis.
Brain
;
Female
;
Fetus/abnormalities*
;
Humans
;
Malformations of Cortical Development/genetics*
;
Pregnancy
;
Prenatal Diagnosis
;
Tubulin/genetics*
;
Whole Exome Sequencing

Result Analysis
Print
Save
E-mail